Bio Green Med Solution (BGMS) vs Imunon (IMNN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Imunon is the larger company by market cap ($6.1 million vs $5.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BGMS | IMNN |
|---|---|---|
| Share price | $0.8001 | $1.10 |
| Market cap | $5.30M | $6.14M |
| 1-day change | -2.55% | +2.34% |
| EPS (TTM) | $-5.02 | $-3.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.70 | $5.39 |
| 52-week low | $0.57 | $1.03 |
| Distance from 52-week high | -88.06% | -79.68% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1452.51% |
| Average volume | 74.12K | 155.30K |
| Shares outstanding | 6.62M | 5.61M |
| Employees | — | 20 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Bio Green Med Solution
BGMS stock →Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems.
Health Care · Biotechnology: Pharmaceutical Preparations
About Imunon
IMNN stock →Imunon, Inc., a clinical-stage biotechnology company, focuses on developing immunotherapies and vaccines in the United States. The company's lead clinical program is IMNN-001, a DNA-based immunotherapy that is in a Phase 3 clinical trial for the localized treatment of advanced ovarian cancer, as well as in the IND-enabling phase for colorectal and pancreatic cancers, and in the discovery phase for glioblastoma.
Health Care · Biotechnology: Pharmaceutical Preparations · 20 employees
BGMS vs IMNN FAQ
Which is bigger, Bio Green Med Solution or Imunon?
Imunon (IMNN) is larger, with a market capitalization of $6.14M compared with $5.30M for Bio Green Med Solution (BGMS).
Are Bio Green Med Solution and Imunon in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.